KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,083 | +38.8% | 2,250 | +12.5% | 0.00% | – |
| Q2 2023 | $28,160 | +30.9% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,520 | -28.2% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $29,960 | +15.2% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +36.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -5.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +4.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -17.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q1 2021 | $74,040,000 | +411233.3% | 4,000 | +300.0% | 0.00% | – |
| Q4 2020 | $18,000 | +125.0% | 1,000 | +100.0% | 0.00% | – |
| Q3 2020 | $8,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |